One study showed that when MSC-NTF cells were administered, it led to a decrease in the levels of NFL and pNfH in ALS participants throughout the experiment [44]; another revealed that the level of NFL would not change in the early trial of studied ALS patients [45]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.